Close

Industry Reports

Bachem reports excellent results for the first half-year 2021

Sales grow by 35.0% to CHF 239.1 million EBITDA rises from CHF 53.0 million to CHF 75.5 million and a margin of 31.6%. Operating...

Samsung Biologics Reports Strong SecondQuarter 2021 Financial Results

Samsung Biologics , a leading contract development and manufacturing organization, announced strong financial results for the secondquarter of fiscal 2021. John Rim, CEO of Samsung Biologics,...

Samsung Biologics Issues Its First Annual Sustainability Report

Samsung Biologics, the world’s leading contract development and manufacturing organization (CDMO), published its first annual sustainability report, consolidating the company’s policies for an enhanced ESG...

Analysis of more than 160,000 COVID-19 patients shows obesity...

Virtual clinical development specialist, Phesi Inc., has today released findings from a significant analysis of COVID-19 patient profiles; based on data from 166,239 COVID-19 patients,...

Real-World Effectiveness And Safety of Teduglutide in Adult Short...

Randomized clinical trials have demonstrated that teduglutide, a glucagon-like peptide-2 (GLP-2) analog, improves intestinal absorption in patients with short bowel syndrome (SBS) with parenteral support...

Artificial Intelligence to play a role in Nutraceuticals industry,...

A global industry survey conducted by Nutrify, the world’s first and only nutraceuticals i2c (ideas to commercialization) platform, has found that there is growing optimism...

Emerging tech will see highest level of investment in...

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences and healthcare R&D, announced findings from a survey conducted at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read